Lugo GAO, Arce GMA, Castillo OGJ, García QR, Sanchez GA, López GHR

Language: Spanish
References: 0
Page: 130-139
PDF size: 250.78 Kb.

ABSTRACT

Introduction: Osteoarthritis is one of the main health problems worldwide due to its high prevalence. Objective: Determine the effectiveness and safety of the treatment with plasma rich in growth factors in knee osteoarthritis. Methods: A study was conducted in health systems and services with a pre-experimental, prospective, open and multicentre systemic approach. The sample consisted of 152 patients who underwent this procedure at the Arnaldo Milián Castro Hospital in Santa Clara from March 2014 to December 2015. The follow-up was carried out at one month, six months and one year. The clinical and hematological variables of the protocol for this procedure were assessed, and specialized scales and laboratory tests were used. The collected data underwent a statistical-mathematical analysis. Results: Knee osteoarthritis predominated in females and in third-age patients; comorbidity was present in most of the patients (arterial hypertension was the most frequent); grades II and III predominated, without association with laterality and the presence of deformity; at one year of treatment, there was a significant reduction in drug consumption, as well as a significant reduction of pain; body weight showed no reduction and there were few complications. Conclusions: The use of plasma rich in autologous growth factors is viable and safe in the treatment of knee osteoarthritis.